Amount of DNA in plasma and cancer risk: A prospective study-Reference-Cited by-同舟云学术

Amount of DNA in plasma and cancer risk: A prospective study

Published:2004 Issue:5 Volume:111 Page:746-749
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Gormally Emmanuelle,Hainaut Pierre,Caboux Elodie,Airoldi Luisa,Autrup Herman,Malaveille Christian,Dunning Alison,Garte Seymour,Matullo Giuseppe,Overvad Kim,Tjonneland Anne,Clavel-Chapelon Francoise,Boffetta Paolo,Boeing Heiner,Trichopoulou Antonia,Palli Domenico,Krogh Vittorio,Tumino Rosario,Panico Salvatore,Bueno-De-Mesquita H. Bas,Peeters Petra H.,Lund Eiliv,Gonzalez Carlos A.,Martinez Carmen,Dorronsoro Miren,Barricarte Aurelio,Tormo M. Jose,Quiros J. Ram�n,Berglund Goran,Hallmans Goran,Day Nicholas E.,Key Timothy J.,Veglia Fabrizio,Peluso Marco,Norat Teresa,Saracci Rodolfo,Kaaks Rudolf,Riboli Elio,Vineis Paolo

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference10 articles.

1. Molecular detection approaches for smoking associated tumors

2. Advances in Cancer Detection

3. Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients

4. Assessment of Plasma DNA Levels, Allelic Imbalance, and CA 125 as Diagnostic Tests for Cancer

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of circulating mitochondrial DNA in prostate cancer and underlying mechanism;Mitochondrion;2023-07

2. Potentiality of Exosomal Proteins as Novel Cancer Biomarkers for Liquid Biopsy;Frontiers in Immunology;2022-06-09

3. BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer;Molecular Oncology;2021-10-12

4. A Pterin-FAM-TAMRA Tri-color Fluorescence Biosensor to Detect the Level of KRAS Point Mutation;Analytical Sciences;2020-12-10

5. Liquid biopsy. A challenge for clinical laboratories;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2020-07-27